ENTL Insider Trading Activity and SEC Form 4 Filings
ENTL insider trading summary
No open-market insider purchases or sales of Entellus Medical Inc (ENTL) have been reported on SEC Form 4 in the past 12 months.
Latest ENTL insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Jan 8, 2018 | Thomas P. Williamson | VP, Commercial Operations | Sell | $36K (1,481 @ $24.12) |
| Jan 5, 2018 | Thomas P. Williamson | VP, Commercial Operations | Sell | $23K (968 @ $24.01) |
| Jan 5, 2018 | Robert S. White | President and CEO | Sell | $83K (3,471 @ $24.01) |
| Jan 5, 2018 | Brent Moen | CFO and Secretary | Sell | $18K (735 @ $24.01) |
| Dec 7, 2017 | Brian E Farley | Director | Sell | $2.4M (101,319 @ $23.85) |
| Oct 20, 2017 | Kevin L Mensink | Vice President, Marketing | Sell | $48K (2,500 @ $19.00) |
| Oct 16, 2017 | Kevin L Mensink | VP Marketing | Sell | $183K (10,000 @ $18.29) |
| Oct 9, 2017 | Karen E Peterson | VP, Regulatory and Quality | Sell | $13K (650 @ $20.17) |
| Oct 4, 2017 | Brian E Farley | Director | Sell | $197K (10,000 @ $19.66) |
| Oct 4, 2017 | Timothy B Petrick | VP, Research & Development | Sell | $40K (2,000 @ $20.01) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.